Lv5
1135 积分 2021-05-28 加入
IKS04, a CanAg-Targeting Antibody–Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models
11天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
12天前
已完结
Antibody-drug conjugates in colorectal cancer: advances, challenges, and prospectives
18天前
已完结
New payloads drive next-gen antibody–drug conjugates
26天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
1个月前
已完结
Emerging principles of cytokine pharmacology and therapeutics
1个月前
已完结
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 Inhibitor
2个月前
已完结
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models
2个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
8个月前
已完结
皖公网安备34019202002308
